Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Infection and Immunity|October 15, 2014
Transgenic expression of CXCR3 on T cells enhances susceptibility to cutaneous Leishmania major infection by inhibiting monocyte maturation and promoting a Th2 responseSteve Oghumu, James C Stock, Sanjay Varikuti, et al.
Infection and Immunity|June 12, 2019
MicroRNA 155 Contributes to Host Immunity against Leishmania donovani but Is Not Essential for Resolution of InfectionSanjay Varikuti, Gayathri Natarajan, Greta Volpedo, et al.
Clinical Transplantation|June 29, 2016
Differential gene expression pattern in biopsies with renal allograft pyelonephritis and allograft rejectionSteve Oghumu, Uday Nori, Anna Bracewell, et al.
Obesity (Silver Spring, Md.)|October 15, 2013
CXCR3 modulates obesity-induced visceral adipose inflammation and systemic insulin resistanceJeffrey A Deiuliis, Steve Oghumu, Dheeraj Duggineni, et al.
Transplantation|February 14, 2014
Acute pyelonephritis in renal allografts: a new role for microRNAs?Steve Oghumu, Anna Bracewell, Uday Nori, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 11, 2024
Host derived macrophage migration inhibitory factor expression attenuates anti-tumoral immune cell accumulation and promotes immunosuppression in the tumor microenvironment of head and neck squamous cell carcinomaNathan Ryan, Felipe Lamenza, Suvekshya Shrestha, et al.
The Journal of Infectious Diseases|September 22, 2018
The Potent ITK/BTK Inhibitor Ibrutinib Is Effective for the Treatment of Experimental Visceral Leishmaniasis Caused by Leishmania donovaniSanjay Varikuti, Greta Volpedo, Noushin Saljoughian, et al.
Scientific Reports|April 27, 2026
Gallic acid chemoprevention of oral carcinogenesis is associated with HSD11β2 upregulation and immune remodelingPuja Upadhaya, Felipe F Lamenza, Ravi Ramalingam, et al.
Molecular Oncology|February 10, 2015
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancerMohamad Elbaz, Mohd W Nasser, Janani Ravi, et al.
Cancer Immunology, Immunotherapy : CII|May 30, 2025
Inhibition of head and neck squamous cell carcinoma by Bruton's tyrosine kinase inhibitor ibrutinib is associated with reduction of immunosuppressive T cellsAnna R Bopp, Felipe F Lamenza, Puja Upadhaya, et al.
Pageof 9